Patient Resources
Get Healthy!
Results for search "Food &, Drug Administration".
Health News Results - 442
Kraft Cheese Slices Recalled Due to Plastic Wrap Choking Hazard
- Cara Murez HealthDay Reporter
- September 22, 2023
- Full Page
Kraft Heinz said it is recalling over 83,000 packs of its Kraft Singles American processed cheese slices because of a packaging defect in the plastic that wraps the cheese slices.
A temporary issue developed on one of the wrapping machines, making it possible for a thin ...
FDA Must Crack Down on Retailers Selling Tobacco to Teens: Report
- Cara Murez HealthDay Reporter
- September 21, 2023
- Full Page
A new government report finds that federal regulators need to do more to help in the battle to keep kids and teens off tobacco.
Among the report’s findings were that the U.S. Food and Drug Administration needs to get tough on retailers selling tobacco to youth and shou...
FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
- Denise Mann HealthDay Reporter
- September 20, 2023
- Full Page
In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions.
Approval of the Neffy nasal spray was widely anticipated. An FDA advisory panel voted ...
Diabetes Drug Maker Sues Over Compounded Versions of Mounjaro
- Cara Murez HealthDay Reporter
- September 20, 2023
- Full Page
Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication.
This time, it’s Eli Lilly suing certain medical spas, wellness ce...
CDC Panel Gives Support to New COVID Booster Shots
- Robin Foster HealthDay Reporter
- September 12, 2023
- Full Page
Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID boosters for Americans.
Final approval is expected from CDC Director Dr. Ma...
FDA Panel Says Common OTC Decongestant Is Useless
- Dennis Thompson HealthDay Reporter
- September 12, 2023
- Full Page
For decades, sick people have been taking essentially worthless over-the-counter cold remedies to clear their stuffy noses, a key advisory panel for the U.S. Food and Drug Administration said Tuesday.
The panel voted unanimously that nonprescription oral medications cont...
FDA Approves New COVID Booster Shots
- Robin Foster HealthDay Reporter
- September 11, 2023
- Full Page
The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days.
The COVID-19 shots from Pfizer and Moderna will join the flu shot and newly approved RSV ...
FDA Approval of New COVID Boosters Could Come by Friday
- Cara Murez HealthDay Reporter
- September 7, 2023
- Full Page
New COVID-19 booster shots could soon pass the needed hurdles for vaccinations to begin next week.
Sources familiar with U.S. Food and Drug Administration plans say boosters could be approved as soon as Friday, NBC News reported.
The U.S. Centers for Disea...
Marijuana Should Be Moved to Lower-Risk Drug Category, U.S. Health Officials Say
- Cara Murez HealthDay Reporter
- August 31, 2023
- Full Page
THURSDAY, Aug. 31, 2023 (HealthDay News) – The U.S. Department of Health and Human Services has asked the U.S. Drug Enforcement Agency to reclassify marijuana as a less dangerous drug under the Controlled Substances Act, a move that could potentially expand acceptance of the...
Don't Use Dr. Berne's and LightEyez Eye Drops Due to Bacteria, Fungus, FDA Says
- Cara Murez HealthDay Reporter
- August 23, 2023
- Full Page
Tainted eye drops are back in the news, with federal regulators warning consumers not to use certain eye drops because of contamination concerns.
Don't Use Certain Tests for Pregnancy, Ovulation, UTIs, FDA Warns
- Cara Murez HealthDay Reporter
- August 14, 2023
- Full Page
The U.S. Food and Drug Administration has warned that consumers should not use certain pregnancy, ovulation, urine, UTI and breast milk test kits over concerns that the tests may not be safe and effective.
The tests in question were manufactured by Universal Meditech Inc...
Tattoo Regret? Here's Tips on Safely Getting Old 'Ink' Removed
- Cara Murez HealthDay Reporter
- August 6, 2023
- Full Page
Whether you got a tattoo on a whim or after much thought, that ink on your body is fairly permanent.
Tattoo removal is possible, but it comes with risks, according to the U.S. Food and Drug Administration, which regulates tattoo ink and pigment, as well as the laser devi...
FDA Gives Approval to Pill to Ease Postpartum Depression
- Denise Mann HealthDay Reporter
- August 5, 2023
- Full Page
The U.S. Food and Drug Administration on Friday approved a new pill, called zuranolone, that may quickly ease severe postpartum depression and help millions of women regain their emotional equilibrium following childbirth.
Taken as a pill once a day for two weeks, zurano...
Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused 'Stomach Paralysis'
- Cara Murez HealthDay Reporter
- August 3, 2023
- Full Page
A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.
Amid Shortages, Federal Agencies Ask Drugmakers to Boost Output of ADHD Meds
- Cara Murez HealthDay Reporter
- August 2, 2023
- Full Page
While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications.
Officials from both the U.S. Food and Drug Administration and the U.S. Drug Enfo...
Pill to Counter Postpartum Depression Looks Good in Trial, May Gain FDA Approval
- Denise Mann HealthDay Reporter
- August 2, 2023
- Full Page
All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may quickly treat and ease severe postpartum depression.
Approval of the drug could help millions of women regain their emotional equilibrium following child...
Here's 8 Habits That Could Lengthen Your Life
- Cara Murez HealthDay Reporter
- July 24, 2023
- Full Page
Eight healthy habits could add years to your life.
A new study of more than 700,000 U.S. veterans breaks down the habits that when adopted by middle age, can help someone live substantially longer than folks who don't have these habits.
These are the big eight:
...
Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial
- Robin Foster HealthDay Reporter
- July 17, 2023
- Full Page
Another experimental drug meant to slow the damage of Alzheimer's appears poised to join a growing arsenal of new treatments for this memory-robbing disease.
FDA Approves First Over-the-Counter Birth Control Pill
- Dennis Thompson HealthDay Reporter
- July 13, 2023
- Full Page
The U.S. Food and Drug Administration on Thursday approved the nation's first over-the-counter birth control pill, a move that will likely pave the way for far greater access to contraception for Americans.
Women will be able to buy the progestin-only oral contraceptive ...
FDA Gives Full Approval to Alzheimer's Drug Leqembi
- Robin Foster HealthDay Reporter
- July 6, 2023
- Full Page
The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer's drug Leqembi, clearing the way for insurance coverage of the pricey drug.
“The full FDA approval will open the floodgates for people with early Alzheimer's to get this drug. It's a ...
FDA Sends Warning to Companies Selling THC Products That Look Like Candy, Cookies
- Cara Murez HealthDay Reporter
- July 5, 2023
- Full Page
Several companies are selling copycat food items that have the potential to trick people, including children, into consuming dangerous quantities of cannabis.
On Wednesday the U.S. Food and Drug Administration and the Federal Trade Commission warned six companies about s...
FDA Approves First Blood Test to Predict Preeclampsia in Pregnant Women
- Cara Murez HealthDay Reporter
- July 5, 2023
- Full Page
A new blood test approved by the U.S. Food and Drug Administration can predict imminent preeclampsia, helping pregnant women who are at risk of this severe and sometimes deadly form of high blood pressure.
The test can identify with 96% accuracy which women with sometime...
FDA Approves First Gene Therapy to Treat Duchenne Muscular Dystrophy
- Steven Reinberg HealthDay Reporter
- June 23, 2023
- Full Page
The U.S. Food and Drug Administration on Thursday approved the drug Elevidys, the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD).
The groundbreaking treatment will not be cheap: Drugmaker Sarepta Therapeutics Inc. said it would ch...
FDA Approves New Drugs to Treat Type 2 Diabetes in Kids
- Cara Murez HealthDay Reporter
- June 21, 2023
- Full Page
The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.
The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provid...
Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
- Cara Murez HealthDay Reporter
- June 21, 2023
- Full Page
The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration.
FDA Advisers Say Next Round of COVID Booster Shots Should Target an XBB Variant
- Robin Foster HealthDay Reporter
- June 15, 2023
- Full Page
An advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken hold in the United States.
Those three XBB varia...
FDA Proposes Tougher Rules for Tattoo Providers to Curb Contaminated Inks
- Cara Murez HealthDay Reporter
- June 15, 2023
- Full Page
Regulators want your next tattoo to be as safe as it is trendy.
The U.S. Food and Drug Administration has issued a draft of new g...
FDA Advisers Meet to Decide Next COVID Booster Shot
- Cara Murez HealthDay Reporter
- June 14, 2023
- Full Page
COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.
Advisers to the U.S. Food and Drug Administration are slated to meet Thursday to discuss plans for fall, a decision with a deadline...
Chinese Company May Help Ease U.S. Shortage of Cancer Drug
- Cara Murez HealthDay Reporter
- June 5, 2023
- Full Page
With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.
The U.S. Food and Drug Administration is working with the Chinese drugmaker Qilu Pharmaceutical to i...
FDA Warns Against Using Bogus Treatments for Skin Condition Molluscum
- Cara Murez HealthDay Reporter
- June 5, 2023
- Full Page
It's tempting to treat little skin bumps on your own, but that delays proper diagnosis and treatment that may work better, federal regulators cautioned.
Among the many types of skin conditions a person can contract are a virus called molluscum, which look like white, pin...
FDA Approves Pfizer's RSV Shot for Older Adults
- Cara Murez HealthDay Reporter
- June 1, 2023
- Full Page
Older adults may have a second vaccine option for RSV following the U.S. Food and Drug Administration's approval of a Pfizer vaccine on Wednesday.
The other shot for adults 60 and up is made by GSK. It was approved May 3.
Both should be available by fall, before th...
FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
- Cara Murez HealthDay Reporter
- May 31, 2023
- Full Page
Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they're getting the medication, the U.S. Food and Drug Administration
FDA Grants Full Approval to Paxlovid to Treat COVID-19
- Cara Murez HealthDay Reporter
- May 25, 2023
- Full Page
Americans with COVID-19 have been taking Paxlovid since it was approved under emergency use in late 2021. Today, the U.S. Food and Drug Administration granted full approval to the drug.
This approval will allow drugmaker Pfizer to sell the medication at market rate once ...
FDA Approves New Nasal Spray to Reverse Overdoses
- Cara Murez HealthDay Reporter
- May 23, 2023
- Full Page
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose.
To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will be available to Americans aged 12 and older with a prescription, the F...
FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease
- Cara Murez HealthDay Reporter
- May 19, 2023
- Full Page
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
Rinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (t...
Think You Need an Opioid? Here Are Questions to Ask Your Doctor
- Cara Murez HealthDay Reporter
- May 14, 2023
- Full Page
It's important to ask questions when your doctor or dentist writes you a new prescription.
This is especially true for opioid pain medications, such as hydrocodone, oxycodone or morphine.
While these drugs are approved by the U.S. Food and Drug Administration for a...
FDA Approves First Nonhormonal Drug to Ease Menopause Hot Flashes
- Ernie Mundell HealthDay Reporter
- May 13, 2023
- Full Page
The U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes.
The new pill, called Veozah (fezolinetant), is from a class of drugs called neurokinin 3 (NK3) receptor antagonists. It targets a specific bra...
FDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergy Attacks
- Cara Murez HealthDay Reporter
- May 12, 2023
- Full Page
Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.
Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adul...
FDA Eases Rules on Gay Men Donating Blood
- Cara Murez HealthDay Reporter
- May 11, 2023
- Full Page
The U.S. Food and Drug Administration on Thursday finalized the elimination of certain restrictions that prevented healthy gay and bisexual men from donating blood.
Instead of requiring men who have sex with men or the women who have sex with them to abstain for sexual ...
FDA Approves First Drug Meant to Ease Alzheimer's-Linked Agitation
- Cara Murez HealthDay Reporter
- May 11, 2023
- Full Page
A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.
The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti ...
FDA Advisors OK Approval of First Over-the-Counter Birth Control Pill
- Robin Foster HealthDay Reporter
- May 10, 2023
- Full Page
In a unanimous vote, a panel of expert advisors to the U.S. Food and Drug Administration on Wednesday endorsed the over-the-counter sale of a birth control pill, a recommendation that will likely pave the way for far greater access to contraception for Americans.
Opill, ...
FDA Experts to Consider First Over-the-Counter Birth Control Pill
- Denise Mann HealthDay Reporter
- May 9, 2023
- Full Page
As a U.S. Food Drug Administration advisory panel prepares to weigh whether to recommend that a birth control pill be sold over the counter in this country, a coalition of advocates on Monday called attention to the safety and effectiveness of the medication.
If approved...
Maker of Wegovy Limits Supply of Obesity Drug in U.S.
- Cara Murez HealthDay Reporter
- May 5, 2023
- Full Page
Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.
The medication is one of three drugs from a class known ...
Experimental Alzheimer's Drug Slows Decline in Thinking in Late-Stage Trial
- Cara Murez HealthDay Reporter
- May 3, 2023
- Full Page
Another experimental drug meant for Alzheimer's disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.
Known as donanemab, the medication clears amyloid plaque from the brain. In a lat...
Young Men Are Using Banned 'SARM' Supplements to Bulk Up, With Harmful Results
- Amy Norton HealthDay Reporter
- May 2, 2023
- Full Page
The U.S. Food and Drug Administration is once again warning consumers to avoid muscle-building "supplements" that are anything but a safe alternative to steroids.
Apetamin: Using This Illegal Weight-Gain Product Can Bring Tragic Results
- Cara Murez HealthDay Reporter
- May 2, 2023
- Full Page
U.S. regulators are urging Americans to avoid Apetamin, an illegal drug used for weight gain and figure enhancement.
The substance, typically sold as a syrup, is manufactured overseas, illegally imported and isn't approved by the U.S. Food and Drug Administration.
General Mills Issues Flour Recall Due to Salmonella Concerns
- Cara Murez HealthDay Reporter
- May 1, 2023
- Full Page
General Mills has recalled four varieties of its Gold Medal flour because of concerns over potential contamination with salmonella.
The recalled flour has “better if used by” dates of March 27, 2024, and March 28, 2024,
U.S. Supreme Court Keeps Abortion Pill Widely Available While Appeal Continues
- Robin Foster HealthDay Reporter
- April 21, 2023
- Full Page
The U.S. Supreme Court ruled on Friday that the abortion pill mifepristone can remain widely available while litigation over its fate winds its way through the court system.
In the meantime, the
Supreme Court Delays Decision on Abortion Pill Ruling
- Robin Foster HealthDay Reporter
- April 20, 2023
- Full Page
The Supreme Court on Wednesday delayed a decision on a federal appeals court ruling that seeks to limit access to the abortion pill mifepristone.
In a brief order, Justice Samuel Alito Jr. said the pause on any decision would lapse Friday at midnight, giving the court...
Groups Ask Supreme Court to Reinstate Restrictions on Abortion Pill Access
- Cara Murez HealthDay Reporter
- April 19, 2023
- Full Page
In the latest move to restrict access to the abortion pill mifepristone in the United States, a coalition of anti-abortion groups on Tuesday asked the Supreme Court to allow an appeals court ruling to stand.